BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//IBSAL - ECPv6.17.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:IBSAL
X-ORIGINAL-URL:https://ibsal.es/en/
X-WR-CALDESC:Events for IBSAL
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251113
DTEND;VALUE=DATE:20260206
DTSTAMP:20251121T082303Z
CREATED:20251121T082303Z
LAST-MODIFIED:20251121T082303Z
UID:25303-1762992000-1770335999@ibsal.es
SUMMARY:AECC Innova 2026 Grants
DESCRIPTION:Purpose and Objectives of the Call for Proposals\nThe primary objective of this call for proposals is to identify projects that undertake an ambitious proof-of-concept study\, which will strengthen previously obtained research results in the field of cancer and initiate the validation process for their commercialization\, while ensuring well-structured intellectual property protection. \nThis call for proposals involves the AECC Patient Advocacy Program\, which is made up of cancer patients and their caregivers.\nAll aspects of the call for proposals will be managed through the Foundation’s grant management platform (Grant Management System\, hereinafter the GMS platform)\, where you can find the relevant documentation. \n  \nRequirements\nResearchers affiliated with public or private\, nonprofit institutions (hereinafter\, “Center”) that have a Knowledge Transfer Office or Innovation Unit are eligible to participate in this call for proposals. Only one application per institution is permitted; therefore\, the KTO must first conduct an internal selection process for the proposed project and submit a report justifying the project’s suitability for participation in this call for proposals. The report must outline the assessment and evaluation criteria used by the KTO in selecting the project.   \nConsortia may not apply\, even if they are composed of two or more centers. \nHowever\, projects may be submitted under this call for proposals if the intellectual property rights\, industrial property rights\, or know-how involved (hereinafter “IPR”) are held by the participating Center on a joint ownership basis with other for-profit or nonprofit entities or individuals\, whether Spanish or foreign\, provided that the provisions of section 10 of the call for proposals are complied with. \nFurthermore\, the intellectual property rights (IPR) involved in the project may be subject to exploitation agreements—such as licensing agreements—with other Spanish or foreign entities\, whether for-profit or nonprofit. \n  \nFeatures of the Proposal\nAny R&D&I project may be submitted\, provided that the feasibility of the expected and/or demonstrable results is at least at TRL 3. These results must have the potential to lead to new opportunities or improvements in various areas of cancer research and across all types of cancer\, provided they accelerate the transfer of results into clinical practice.  \nThis call for proposals is open to all projects aimed at bringing research closer to patients and whose application of scientific and technical knowledge improves the prevention\, diagnosis\, and/or treatment of cancer patients. \nAreas eligible for financial support: \n— Development of new therapies\, diagnostic methods\, and biomedical technologies\n— Medtech innovation for education and clinical practice \n  \nFeatures of the Grant\nDuration \nThe grant will have a maximum duration of 2 years from the start date specified in the specific annex to the framework agreement that will govern the terms of the grant. \nHowever\, the research team must carry out the project within the number of months ultimately specified in the work plan set forth in the scientific report. \n  \nFinancial Assistance \nThe maximum total amount of funding for the winning project is 180\,000 euros. \nThe amount of the grant will be determined by the Foundation\, based on the eligible costs documented in the application and depending on the specific needs and circumstances of each project. \n  \nSubmission of Applications\nApplicants must register on the GMS platform  https://grants-fundacioncientifica-aecc.smartsimple.ie/s_Login.jsp \nDocuments will only be accepted through this channel; documents submitted through any other channel will not be accepted. \n  \nDeadline for submitting applications\nThe application period begins on November 13\, 2025\, and ends on February 5\, 2026\, at 3:00 p.m. (Peninsular time). \nThe system will not accept submissions after the application deadline\, and only those applications submitted within the application period will be evaluated. \n  \nComplete guidelines for the call for applications\nhttps://www.contraelcancer.es/sites/default/files/ayudas/2025-11/Bases_Proyectos_AECC%20INNOVA_2026.pdf
URL:https://ibsal.es/en/evento/aecc-innova-2026-grants/
CATEGORIES:Calls for research
END:VEVENT
END:VCALENDAR